Hsp70: A chaperokine

Novartis Foundation Symposium

Volumn 291, Issue , 2008, Pages 173-179

  Asea, Alexzander ^a  

^a TEXAS A AND M UNIVERSITY SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 72;

ANIMAL; ARTICLE; HUMAN; METABOLISM; MOUSE;

ANIMALS; CYTOKINES; HSP70 HEAT-SHOCK PROTEINS; HSP72 HEAT-SHOCK PROTEINS; HUMANS; MICE;

EID: 52449085880     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (51)

1. Adewoye AH, Klings ES, Farber HW et al 2005 Sickle cell vaso-occlusive crisis induces the release of circulating serum heat shock protein-70. Am J Hematol 78:240-242
2. Asea A 2003 Chaperokine-induced signal transduction pathways. Exerc Immunol Rev 9:25-33
3. Asea A 2007 Release of heat shock proteins: passive vs active release mechanisms. In: Asea A, DeMaio A (eds) Heat shock proteins: potent mediators of inflammation and immunity. Springer Publishers, Dordrecht, The Netherlands, p 3-20
4. Asea A, Kabingu E, Stevenson MA, Calderwood SK 2000a HSP70 peptide-bearing and peptide-negative preparations act as chaperokines. Cell Stress Chaperones 5:425-431
5. Asea A, Kraeft SK, Kurt-Jones EA et al 2000b HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 6:435-442
6. Asea A, Rehli M, Kabingu E et al 2002 Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 277:15028-15034
7. Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK 2000 Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol 12:1539-1546
8. Bausero MA, Gastpar R, Multhoff G, Asea A 2005 Alternative mechanism by which IFN-γ enhances tumor recognition: active release of heat shock protein 72. J Immunol 175:2900-2912
9. Binder RJ, Anderson KM, Basu S, Srivastava PK 2000a Cutting edge: heat shock protein gp96 induces maturation and migration of CD11c+ cells in vivo. J Immunol 165:6029-6035
10. Binder RJ, Harris, ML, Menoret A, Srivastava PK 2000b Saturation, competition, and specificity in interaction of heat shock proteins (hsp) gp96, hsp90, and hsp70 with CD11b+ cells. J Immunol 165:2582-2587
11. Bogers WM, Bergmeier LA, Ma J et al 2004a A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection. AIDS 18:25-36
12. Bogers WM, Bergmeier LA, Oostermeijer H et al 2004b CCR5 targeted SIV vaccination strategy preventing or inhibiting SIV infection. Vaccine 22:2974-2984
13. Calderwood SK 2005 Chaperones and slow death-a recipe for tumor immunotherapy. Trends Biotechnol 23:57-59
14. Casey DG, Lysaght J, James T, Bateman A, Melcher AA, Todryk SM 2003 Heat shock protein derived from a non-autologous tumour can be used as an anti-tumour vaccine. Immunology 110:105-111
15. Chen W, Lin Y, Liao C, Hsieh S 2000 Modulatory effects of the human heat shock protein 70 on DNA vaccination. J Biomed Sci 7:412-419
16. Dybdahl B, Slordahl SA, Waage A, Kierulf P, Espevik T, Sundan A 2005 Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction. Heart 91:299-304
17. Fleshner M, Campisi J, Amiri L, Diamond DM 2004 Cat exposure induces both intra- and extracellular Hsp72: the role of adrenal hormones. Psychoneuroendocrinology 29:1142-1152
18. Gallucci S, Matzinger P 2001 Danger signals: SOS to the immune system. Curr Opin Immunol 13:114-19
19. Gastpar R, Gehrmann M, Bausero MA et al 2005 Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res 65:5238-5247
20. Heike M, Blachere NE, Srivastava PK 1994 Protective cellular immunity against a spontaneous mammary carcinoma from ras transgenic mice. Immunobiology 190:411-423
21. Huang XF, Ren W, Rollins L et al 2003 A broadly applicable, personalized heat shock protein-mediated oncolytic tumor vaccine. Cancer Res 63:7321-7329
22. Kawabata Y, Udono H, Honma K et al 2002 Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii. Infect Immun 70:6075-6082
23. Lancaster GI, Moller K, Nielsen B et al 2004 Exercise induces the release of heat shock protein 72 from the human brain in vivo. Cell Stress Chaperones 9:276-280
24. Lehner T, Bergmeier LA, Wang Y et al 2000 Heat shock proteins generate beta-chemokines which function as innate adjuvants enhancing adaptive immunity. Eur J Immunol 30:594-603
25. Li Z, Srivastava PK 1993 Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation. EMBO J 12:3143-3151
26. Mambula SS, Calderwood SK 2006 Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes. J Immunol 177:7849-7857
27. Matzinger P 1998 An innate sense of danger. Semin Immunol 10:399-415
28. Millar DG, Garza KM, Odermatt B et al 2003 Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo. Nat Med 9:1469-1476
29. Moehler MH, Zeidler M, Wilsberg V et al 2005 Parvovirus H-1-induced tumor cell death enhances human immune response in vitro via increased phagocytosis, maturation, and cross-presentation by dendritic cells. Hum Gene Ther 16:996-1005
30. Noessner E, Gastpar R, Milani V et al 2002 Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells. J Immunol 169:5424-5432
31. Oglesbee MJ, Pratt M, Carsillo T 2002 Role for heat shock proteins in the immune response to measles virus infection. Viral Immunol 15:399-416
32. Panjwani NN, Popova L, Srivastava PK 2002 Heat shock proteins gp96 and hsp70 activate the release of nitric oxide by APCs. J Immunol 168:2997-3003
33. Pittet JF, Lee H, Morabito D, Howard MB, Welch WJ, Mackersie RC 2002 Serum levels of Hsp 72 measured early after trauma correlate with survival. J Trauma 52:611-617; discussion 617
34. Pockley AG, De Faire U, Kiessling R, Lemne C, Thulin T, Frostegard J 2002 Circulating heat shock protein and heat shock protein antibody levels in established hypertension. J Hypertens 20:1815-1820
35. Pockley AG, Georgiades A, Thulin T, de Faire U, Frostegard J 2003 Serum heat shock protein 70 levels predict the development of atherosclerosis in subjects with established hypertension. Hypertension 42:235-238
36. Qazi KR, Wikman M, Vasconcelos NM, Berzins K, Stahl S, Fernandez C 2005 Enhancement of DNA vaccine potency by linkage of Plasmodium falciparum malarial antigen gene fused with a fragment of HSP70 gene. Vaccine 23:1114-1125
37. Singh-Jasuja H, Scherer HU, Hilf N et al 2000 The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur J Immunol 30:2211-2215
38. Srivastava PK 2000 Heat shock protein-based novel immunotherapies. Drug News Perspect 13:517-522
39. Srivastava P 2002 Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu Rev Immunol 20:395-425
40. Srivastava PK 2005 Immunotherapy for human cancer using heat shock protein-peptide complexes. Curr Oncol Rep 7:104-108
41. Srivastava PK 2006 Therapeutic cancer vaccines. Curr Opin Immunol 18:201-5
42. Srivastava PK, Udono H 1994 Heat shock protein-peptide complexes in cancer immunotherapy. Curr Opin Immunol 6:728-732
43. Srivastava PK, Udono H, Blachere NE, Li Z 1994 Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics 39:93-98
44. Suzue K, Young RA 1996a Adjuvant-free hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24. J Immunol 156:873-879
45. Suzue K, Young RA 1996b Heat shock proteins as immunological carriers and vaccines. EXS 77:451-465
46. Suzue K, Zhou X, Eisen HN, Young RA 1997 Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway. Proc Natl Acad Sci USA 94:13146-13151
47. Udono H, Srivastava PK 1993 Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med 178:1391-1396
48. Wang XY, Chen X, Manjili MH, Repasky E, Henderson R, Subjeck JR 2003a Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100. Cancer Res 63:2553-2560
49. Wang XY, Kazim L, Repasky EA, Subjeck JR 2003b Immunization with tumor-derived ER chaperone grp170 elicits tumor-specific CD8+ T-cell responses and reduces pulmonary metastatic disease. Int J Cancer 105:226-231
50. Wang Y, Whittall T, McGowan E et al 2005 Identification of stimulating and inhibitory epitopes within the heat shock protein 70 molecule that modulate cytokine production and maturation of dendritic cells. J Immunol 174:3306-3316
51. Wright BH, Corton JM, El-Nahas AM, Wood RF, Pockley AG 2000 Elevated levels of circulating heat shock protein 70 (Hsp70) in peripheral and renal vascular disease. Heart Vessels 15:18-22